KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

Practices in the Management of Kidney Transplant Candidates and Recipients with Obesity: A Survey of U.S. Transplant Programs

Puttarajappa CM, Urbanski M, Fallahzadeh MK, Budhiraja P, Balaraman V, Butsch WS, Morford H, Anand PM, Woodside KJ, Orandi BJ; co-authors; American Society of Transplantation[...]

A Bayesian Joint Model of Longitudinal Kidney Disease Progression, Recurrent Cardiovascular Events, and Terminal Event in Patients with Chronic Kidney Disease

Kürüm E, Kwan B, Qian Q, Banerjee S, Rhee CM, Nguyen DV, Şentürk D. A Bayesian Joint Model of Longitudinal Kidney Disease Progression, Recurrent Cardiovascular[...]

Improvement of Kidney Function Following Unilateral Nephrectomy in a Patient With Cardiovascular-Kidney-Metabolic (CKM) Syndrome

Asopa M, Kamgar M, Wilson J, Emami S, Shuch B, Nobakht N. Improvement of Kidney Function Following Unilateral Nephrectomy in a Patient With Cardiovascular-Kidney-Metabolic (CKM)[...]